Page last updated: 2024-12-05

benzothiazole

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Benzothiazole is a heterocyclic aromatic compound containing a benzene ring fused to a thiazole ring. It is a colorless liquid with a characteristic odor. Benzothiazole and its derivatives have a wide range of applications in various fields, including pharmaceuticals, dyes, and agrochemicals. Benzothiazole is a versatile building block for the synthesis of a wide range of heterocyclic compounds. It can be synthesized via several methods, including the reaction of o-aminothiophenol with aldehydes or ketones. Benzothiazole derivatives exhibit a wide range of biological activities, including antibacterial, antifungal, anti-inflammatory, and anticancer properties. They are also used as fluorescent probes and dyes. The unique electronic properties of benzothiazole, such as its electron-withdrawing nature and ability to form stable cationic species, make it an important component in various electronic and optoelectronic devices. Benzothiazole derivatives are also used as corrosion inhibitors, stabilizers for polymers, and as intermediates in the production of other fine chemicals.'

benzothiazole: structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

benzothiazole : An organic heterobicyclic compound that is a fusion product between benzene and thiazole. The parent of the class of benzothiazoles. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID7222
CHEMBL ID510309
CHEBI ID45993
SCHEMBL ID8430
SCHEMBL ID9304593
MeSH IDM0047033

Synonyms (74)

Synonym
AC-3297
benzothiazole
1-thia-3-azaindene
usaf ek-4812
nsc-8040
vangard bt
nsc8040
95-16-9
benzosulfonazole
wln: t56 bn dsj
o-2857
AC-907/25014160
smr001216577
MLS001050134
bt
inchi=1/c7h5ns/c1-2-4-7-6(3-1)8-5-9-7/h1-5
1,3-benzothiazole
NCGC00091399-01
brn 0109468
nsc 8040
fema no. 3256
ai3-05742
fema number 3256
hsdb 2796
ccris 7893
einecs 202-396-2
benzothiazole, >=96%, fg
BOT ,
benzothiazole, 96%
benzothiazol
CHEBI:45993 ,
B0092
CHEMBL510309
benzo[d]thiazole
FT-0662581
AKOS000120178
NCGC00091399-02
benzthiazole
dtxcid204586
tox21_303232
dtxsid7024586 ,
cas-95-16-9
NCGC00257070-01
NCGC00259402-01
tox21_201853
ec 202-396-2
4-27-00-01069 (beilstein handbook reference)
g5bw2593ep ,
unii-g5bw2593ep
FT-0622731
EPITOPE ID:138946
bdbm50444460
STL268890
benzothiazole [mi]
benzothiazole [hsdb]
benzothiazole [fhfi]
SCHEMBL8430
SCHEMBL9304593
1,3-benzothiazole #
Q-100900
CS-W013350
mfcd00005775
F0001-2268
benzothiazole, analytical standard
LT0034
benzothiazole, vetec(tm) reagent grade, 96%
Q419096
AMY23315
FS-4155
D77749
s-benzothiazole
EN300-19148
HY-W012634
Z104472964

Research Excerpts

Overview

Benzothiazole is a benzofused heterocyclic that is widely reported as a constituent of naturally occurring chemicals. Benzothiazoles are a part of the molecular structure of a large number of natural products, biocides, drugs, food flavors, and industrial chemicals.

ExcerptReferenceRelevance
"Benzothiazole is a benzofused heterocyclic that is widely reported as a constituent of naturally occurring chemicals and chiefly responsible for their pharmacological potential."( Insight into the Synthesis, Biological Activity, and Structure-activity Relationship of Benzothiazole and Benzothiazole-hydrazone Derivatives: A Comprehensive Review.
Abdullah, MM; Chauhan, B; Kumar, R; Mazumder, A; Singh, H; Yadav, RK, 2023
)
1.85
"Benzothiazole is a heterocyclic aromatic and bicyclic compound in which, benzene ring is attached with thiazole ring. "( Advancement in Pharmacological Activities of Benzothiazole and its Derivatives: An Up to Date Review.
Kumar, A; Mishra, AK, 2021
)
2.32
"Benzothiazole (BZO) is an antimicrobial secondary metabolite volatilized by many plants and microbes. "( Benzothiazole inhibits the growth of Phytophthora capsici through inducing apoptosis and suppressing stress responses and metabolic detoxification.
Du, F; Huang, H; Huang, L; Li, Y; Liu, Y; Mei, X; Wu, J; Yang, M; Zhu, S, 2019
)
3.4
"Benzothiazole (BT) is a natural and synthetic compound occurring in aquatic sediments and wastewater. "( Transformation of benzothiazole in estuarine sediments.
Catallo, WJ; Junk, T,
)
1.91
"Benzothiazoles are a part of the molecular structure of a large number of natural products, biocides, drugs, food flavors, and industrial chemicals. "( Analysis of benzothiazole in Italian wines using headspace solid-phase microextraction and gas chromatography-mass spectrometry.
Bellavia, V; Fanelli, R; Natangelo, M; Rotilio, D, 2000
)
2.13

Effects

Benzothiazole molecule has a heterocyclic structure, basic in nature with wide variety of active sites. As benzothiazol has proven to be good antimicrobial agent, a novel series of Schiff bases of benzothsiazole derivatives were synthesized.

ExcerptReferenceRelevance
"Benzothiazole molecule has a heterocyclic structure, basic in nature with wide variety of active sites."( Anticonvulsant and neurological profile of benzothiazoles: a mini-review.
Gagoria, J; Khatkar, A; Verma, PK, 2015
)
1.4
"Benzothiazole molecule has a heterocyclic structure, basic in nature with wide variety of active sites."( Anticonvulsant and neurological profile of benzothiazoles: a mini-review.
Gagoria, J; Khatkar, A; Verma, PK, 2015
)
1.4
"As benzothiazole has proven to be good antimicrobial agent, a novel series of Schiff bases of benzothiazole derivatives were synthesized. "( Synthesis and evaluation of some new benzothiazole derivatives as potential antimicrobial agents.
Bhandari, A; Ranawat, MS; Sharma, R; Sharma, S; Soni, B, 2010
)
1.25
"Benzothiazole has been the primary rubber-related chemical found in synthetic turf studies."( Benzothiazole toxicity assessment in support of synthetic turf field human health risk assessment.
Ginsberg, G; Kurland, T; Toal, B, 2011
)
2.53

Treatment

ExcerptReferenceRelevance
"Benzothiazole treatment did not induce any cytotoxic effect on HeLa DH cells after 48 h of incubation."( Inhibition of cervical cancer cell metastasis by benzothiazole through up-regulation of E-cadherin expression.
Cui, Z; Li, J; Liu, W; Mao, X; Zhang, X; Zhao, J, 2017
)
1.43

Toxicity

ExcerptReferenceRelevance
"A Quick, Easy, Cheap, Effective, Rugged and Safe (QuEChERS) extraction method followed by liquid chromatography-(Orbitrap) high resolution mass spectrometry was developed for the simultaneous determination of five benzotriazole, four benzothiazole and five benzenesulfonamide derivates in sewage sludge."( A quick, easy, cheap, effective, rugged and safe extraction method followed by liquid chromatography-(Orbitrap) high resolution mass spectrometry to determine benzotriazole, benzothiazole and benzenesulfonamide derivates in sewage sludge.
Borrull, F; Herrero, P; Marcé, RM; Pocurull, E, 2014
)
0.78

Pharmacokinetics

ExcerptReferenceRelevance
" These findings warrant further evaluation of their properties in an effort to identify valuable alternatives to Ritonavir as pharmacokinetic enhancers."( Benzoxazole and benzothiazole amides as novel pharmacokinetic enhancers of HIV protease inhibitors.
Baumeister, J; Haché, G; Hallenberger, S; Jonckers, TH; Rouan, MC; Sasaki, JC; Schepens, W, 2012
)
0.72

Bioavailability

ExcerptReferenceRelevance
" Inhibitor 16 also demonstrated good plasma levels and oral bioavailability in dogs, while monkey exposure was rather low."( 5-Benzothiazole substituted pyrimidine derivatives as HCV replication (replicase) inhibitors.
Alvarez, C; Ananthan, S; Arasappan, A; Bennett, F; Chase, R; Chen, L; Clark, JL; Curry, S; Fowler, AT; Gavalas, S; Geng, F; Girijavallabhan, V; Huang, HC; Huang, Y; Huelgas, R; Kezar, HS; Kim, SH; Kosinski, A; Kozlowski, J; Kwong, CD; Li, C; MacCoss, M; Maddry, JA; Njoroge, FG; Pinto, P; Piwinski, JJ; Reynolds, RC; Rizvi, R; Rossman, R; Roychowdhury, A; Secrist, JA; Shankar, B; Shih, NY; Tong, L; Tong, X; Velazquez, F; Venkatraman, S; Verma, VA, 2012
)
1.1
" In phase IV screening, the bioavailability of active compounds was assessed on oral administration."( Preliminary anticonvulsant and toxicity screening of substituted benzylidenehydrazinyl-N-(6-substituted benzo[d]thiazol-2-yl)propanamides.
Ali, R; Siddiqui, N, 2014
)
0.4

Dosage Studied

ExcerptRelevanceReference
" The parent molecule 5a shows potent inhibitory activity in vitro in the nanomolar range against a panel of human breast cancer cell lines, but is inactive (IC50 > 30 microM) against other cell types: activity against the sensitive breast lines MCF-7 and MDA 468 is characterized by a biphasic dose-response relationship."( Antitumor benzothiazoles. 3. Synthesis of 2-(4-aminophenyl)benzothiazoles and evaluation of their activities against breast cancer cell lines in vitro and in vivo.
Bradshaw, TD; Fichtner, I; Lelieveld, P; McCall, CJ; Shi, DF; Stevens, MF; Wrigley, S, 1996
)
0.7
" Biphasic dose-response relationships were observed in sensitive cell lines after 48-h drug exposure."( Influence of 2-(4-aminophenyl)benzothiazoles on growth of human ovarian carcinoma cells in vitro and in vivo.
Bradshaw, TD; Fiebig, HH; Garner, C; Kelland, L; Paull, KD; Schultz, RJ; Shi, DF; Stevens, MF; Wilson, A; Wrigley, S, 1998
)
0.59
" Selected compounds were screened for in vitro schistosomicidal activity against Schistosoma mansoni at three different dosage levels (10, 50 and 100 microg/mL)."( Synthesis and in vitro evaluation of new benzothiazole derivatives as schistosomicidal agents.
Mahran, MA; Ramzy, F; Sembel, AM; William, S, 2007
)
0.61
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (3)

RoleDescription
plant metaboliteAny eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms.
xenobioticA xenobiotic (Greek, xenos "foreign"; bios "life") is a compound that is foreign to a living organism. Principal xenobiotics include: drugs, carcinogens and various compounds that have been introduced into the environment by artificial means.
environmental contaminantAny minor or unwanted substance introduced into the environment that can have undesired effects.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
benzothiazoles
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (14)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, HADH2 proteinHomo sapiens (human)Potency39.81070.025120.237639.8107AID886
Chain B, HADH2 proteinHomo sapiens (human)Potency39.81070.025120.237639.8107AID886
LuciferasePhotinus pyralis (common eastern firefly)Potency70.97990.007215.758889.3584AID1224835
RAR-related orphan receptor gammaMus musculus (house mouse)Potency54.48270.006038.004119,952.5996AID1159521
AR proteinHomo sapiens (human)Potency8.69780.000221.22318,912.5098AID1259247; AID743035
aldehyde dehydrogenase 1 family, member A1Homo sapiens (human)Potency25.11890.011212.4002100.0000AID1030
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency61.37490.003041.611522,387.1992AID1159552; AID1159555
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency24.48460.001530.607315,848.9004AID1224841; AID1259401
peroxisome proliferator-activated receptor deltaHomo sapiens (human)Potency0.00620.001024.504861.6448AID743215
aryl hydrocarbon receptorHomo sapiens (human)Potency21.83380.000723.06741,258.9301AID743085; AID743122
gemininHomo sapiens (human)Potency0.05800.004611.374133.4983AID624297
TAR DNA-binding protein 43Homo sapiens (human)Potency35.48131.778316.208135.4813AID652104
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Indoleamine 2,3-dioxygenase 1Homo sapiens (human)IC50 (µMol)652.00000.05373.075710.0000AID1059429
Mu-type opioid receptorMus musculus (house mouse)IC50 (µMol)652.00000.00081.699210.0000AID1059429
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (37)

Processvia Protein(s)Taxonomy
regulation of activated T cell proliferationIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
positive regulation of T cell tolerance inductionIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
positive regulation of chronic inflammatory responseIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
positive regulation of type 2 immune responseIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
tryptophan catabolic processIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
inflammatory responseIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
female pregnancyIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
tryptophan catabolic process to kynurenineIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
response to lipopolysaccharideIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
negative regulation of interleukin-10 productionIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
positive regulation of interleukin-12 productionIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
multicellular organismal response to stressIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
kynurenic acid biosynthetic processIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
swimming behaviorIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
T cell proliferationIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
negative regulation of T cell proliferationIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
negative regulation of T cell apoptotic processIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
positive regulation of T cell apoptotic processIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
'de novo' NAD biosynthetic process from tryptophanIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
negative regulation of protein phosphorylationTAR DNA-binding protein 43Homo sapiens (human)
mRNA processingTAR DNA-binding protein 43Homo sapiens (human)
RNA splicingTAR DNA-binding protein 43Homo sapiens (human)
negative regulation of gene expressionTAR DNA-binding protein 43Homo sapiens (human)
regulation of protein stabilityTAR DNA-binding protein 43Homo sapiens (human)
positive regulation of insulin secretionTAR DNA-binding protein 43Homo sapiens (human)
response to endoplasmic reticulum stressTAR DNA-binding protein 43Homo sapiens (human)
positive regulation of protein import into nucleusTAR DNA-binding protein 43Homo sapiens (human)
regulation of circadian rhythmTAR DNA-binding protein 43Homo sapiens (human)
regulation of apoptotic processTAR DNA-binding protein 43Homo sapiens (human)
negative regulation by host of viral transcriptionTAR DNA-binding protein 43Homo sapiens (human)
rhythmic processTAR DNA-binding protein 43Homo sapiens (human)
regulation of cell cycleTAR DNA-binding protein 43Homo sapiens (human)
3'-UTR-mediated mRNA destabilizationTAR DNA-binding protein 43Homo sapiens (human)
3'-UTR-mediated mRNA stabilizationTAR DNA-binding protein 43Homo sapiens (human)
nuclear inner membrane organizationTAR DNA-binding protein 43Homo sapiens (human)
amyloid fibril formationTAR DNA-binding protein 43Homo sapiens (human)
regulation of gene expressionTAR DNA-binding protein 43Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (15)

Processvia Protein(s)Taxonomy
electron transfer activityIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
heme bindingIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
indoleamine 2,3-dioxygenase activityIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
metal ion bindingIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
tryptophan 2,3-dioxygenase activityIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
RNA polymerase II cis-regulatory region sequence-specific DNA bindingTAR DNA-binding protein 43Homo sapiens (human)
DNA bindingTAR DNA-binding protein 43Homo sapiens (human)
double-stranded DNA bindingTAR DNA-binding protein 43Homo sapiens (human)
RNA bindingTAR DNA-binding protein 43Homo sapiens (human)
mRNA 3'-UTR bindingTAR DNA-binding protein 43Homo sapiens (human)
protein bindingTAR DNA-binding protein 43Homo sapiens (human)
lipid bindingTAR DNA-binding protein 43Homo sapiens (human)
identical protein bindingTAR DNA-binding protein 43Homo sapiens (human)
pre-mRNA intronic bindingTAR DNA-binding protein 43Homo sapiens (human)
molecular condensate scaffold activityTAR DNA-binding protein 43Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (14)

Processvia Protein(s)Taxonomy
cytosolIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
smooth muscle contractile fiberIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
stereocilium bundleIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
cytoplasmIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
plasma membraneMu-type opioid receptorMus musculus (house mouse)
intracellular non-membrane-bounded organelleTAR DNA-binding protein 43Homo sapiens (human)
nucleusTAR DNA-binding protein 43Homo sapiens (human)
nucleoplasmTAR DNA-binding protein 43Homo sapiens (human)
perichromatin fibrilsTAR DNA-binding protein 43Homo sapiens (human)
mitochondrionTAR DNA-binding protein 43Homo sapiens (human)
cytoplasmic stress granuleTAR DNA-binding protein 43Homo sapiens (human)
nuclear speckTAR DNA-binding protein 43Homo sapiens (human)
interchromatin granuleTAR DNA-binding protein 43Homo sapiens (human)
nucleoplasmTAR DNA-binding protein 43Homo sapiens (human)
chromatinTAR DNA-binding protein 43Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (21)

Assay IDTitleYearJournalArticle
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID1745845Primary qHTS for Inhibitors of ATXN expression
AID651635Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression
AID756681Activation of AMPK in rat L6 cells assessed as increase of [3H]dGlc uptake at 100 uM after 5 hrs in presence of insulin2013Journal of medicinal chemistry, Jul-11, Volume: 56, Issue:13
Synthesis and mechanism of hypoglycemic activity of benzothiazole derivatives.
AID1059430Inhibition of recombinant human IDO1 expressed in Escherichia coli EC538 using L-tryptophan as substrate at 1 mM after 1 hr relative to control2013Bioorganic & medicinal chemistry, Dec-15, Volume: 21, Issue:24
Discovery and characterisation of hydrazines as inhibitors of the immune suppressive enzyme, indoleamine 2,3-dioxygenase 1 (IDO1).
AID756690Activation of AMPK in rat L6 cells assessed as increase of [3H]dGlc uptake at 100 uM after 5 hrs relative to control2013Journal of medicinal chemistry, Jul-11, Volume: 56, Issue:13
Synthesis and mechanism of hypoglycemic activity of benzothiazole derivatives.
AID1887063Cytotoxicity against human HCT-116 cells assessed as reduction in cell viability incubated for 3 days by methylene blue staining based analysis2022Journal of medicinal chemistry, 09-08, Volume: 65, Issue:17
Tunable Cysteine-Targeting Electrophilic Heteroaromatic Warheads Induce Ferroptosis.
AID346025Binding affinity to beta cyclodextrin2009Bioorganic & medicinal chemistry, Jan-15, Volume: 17, Issue:2
Convenient QSAR model for predicting the complexation of structurally diverse compounds with beta-cyclodextrins.
AID343680Hexadecane-water distribution coefficient, log D at pH 7.4 by shake-flask technique2008Journal of medicinal chemistry, Jul-10, Volume: 51, Issue:13
Toward prediction of alkane/water partition coefficients.
AID1059429Inhibition of recombinant human IDO1 expressed in Escherichia coli EC538 using L-tryptophan as substrate after 1 hr2013Bioorganic & medicinal chemistry, Dec-15, Volume: 21, Issue:24
Discovery and characterisation of hydrazines as inhibitors of the immune suppressive enzyme, indoleamine 2,3-dioxygenase 1 (IDO1).
AID1887064Cytotoxicity against human NCI-H522 cells assessed as reduction in cell viability incubated for 3 days by methylene blue staining based analysis2022Journal of medicinal chemistry, 09-08, Volume: 65, Issue:17
Tunable Cysteine-Targeting Electrophilic Heteroaromatic Warheads Induce Ferroptosis.
AID343398Octanol-water distribution coefficient, log D at pH 7.4 by shake-flask technique2008Journal of medicinal chemistry, Jul-10, Volume: 51, Issue:13
Toward prediction of alkane/water partition coefficients.
AID756686Activation of AMPKalpha in rat L6 cells assessed as phosphorylation at Thr172 after 40 mins to 24 hrs by Western blot analysis2013Journal of medicinal chemistry, Jul-11, Volume: 56, Issue:13
Synthesis and mechanism of hypoglycemic activity of benzothiazole derivatives.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (520)

TimeframeStudies, This Drug (%)All Drugs %
pre-199025 (4.81)18.7374
1990's30 (5.77)18.2507
2000's105 (20.19)29.6817
2010's298 (57.31)24.3611
2020's62 (11.92)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 68.18

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index68.18 (24.57)
Research Supply Index6.28 (2.92)
Research Growth Index5.15 (4.65)
Search Engine Demand Index116.92 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (68.18)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews30 (5.65%)6.00%
Case Studies2 (0.38%)4.05%
Observational0 (0.00%)0.25%
Other499 (93.97%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]